| First Author | Kittaka M | Year | 2020 |
| Journal | J Bone Miner Res | Volume | 35 |
| Issue | 2 | Pages | 382-395 |
| PubMed ID | 31613396 | Mgi Jnum | J:326175 |
| Mgi Id | MGI:7287932 | Doi | 10.1002/jbmr.3882 |
| Citation | Kittaka M, et al. (2020) Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts. J Bone Miner Res 35(2):382-395 |
| abstractText | Periodontitis is a bacterially induced chronic inflammatory condition of the oral cavity where tooth-supporting tissues including alveolar bone are destructed. Previously, we have shown that the adaptor protein SH3-domain binding protein 2 (SH3BP2) plays a critical role in inflammatory response and osteoclastogenesis of myeloid lineage cells through spleen tyrosine kinase (SYK). In this study, we show that SH3BP2 is a novel regulator for alveolar bone resorption in periodontitis. Micro-CT analysis of SH3BP2-deficient (Sh3bp2 (-/-) ) mice challenged with ligature-induced periodontitis revealed that Sh3bp2 (-/-) mice develop decreased alveolar bone loss (male 14.9% +/- 10.2%; female 19.0% +/- 6.0%) compared with wild-type control mice (male 25.3% +/- 5.8%; female 30.8% +/- 5.8%). Lack of SH3BP2 did not change the inflammatory cytokine expression and osteoclast induction. Conditional knockout of SH3BP2 and SYK in myeloid lineage cells with LysM-Cre mice recapitulated the reduced bone loss without affecting both inflammatory cytokine expression and osteoclast induction, suggesting that the SH3BP2-SYK axis plays a key role in regulating alveolar bone loss by mechanisms that regulate the bone-resorbing function of osteoclasts rather than differentiation. Administration of a new SYK inhibitor GS-9973 before or after periodontitis induction reduced bone resorption without affecting inflammatory reaction in gingival tissues. In vitro, GS-9973 treatment of bone marrow-derived M-CSF-dependent macrophages suppressed tartrate-resistant acid phosphatase (TRAP)-positive osteoclast formation with decreased mineral resorption capacity even when GS-9973 was added after RANKL stimulation. Thus, the data suggest that SH3BP2-SYK is a novel signaling axis for regulating alveolar bone loss in periodontitis and that SYK can be a potential therapeutic target to suppress alveolar bone resorption in periodontal diseases. (c) 2019 American Society for Bone and Mineral Research. (c) 2019 American Society for Bone and Mineral Research. |
